Amersham Health S.A.
Vélizy-Villacoublay, 78457, France
NCT Number: NCT00209404
Image quality in coronary artery computed tomography is influenced by the heart rate variation during the examination. The purpose of this clinical trial is to investigate the change in heart rate following injection of a contrast medium called Visipaque™ (iodixanol). Image quality and diagnostic quality of the examination will be evaluated.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Vélizy-Villacoublay, 78457, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Looking for future studies?
Notify MeGE Healthcare
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04627220
Arterial Occlusive Diseases, Arteriosclerosis
Bursa, Turkey (Türkiye)
View Trial DetailsNCT06943157
Arterial Occlusive Diseases, Arteriosclerosis
Adıyaman, Turkey (Türkiye)
View Trial DetailsNCT05514938
Acute Coronary Syndrome, Arterial Occlusive Diseases
Dallas, Texas, United States
View Trial DetailsNCT04654052
Acute Coronary Syndrome, Acute Myocardial Infarction
El Palmar, Murcia, Spain
View Trial Details